Possible relationship between electroencephalogram finding and lithium response in bipolar disorder

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 5, 2002, Pages 903-907

  Ikeda, Akifumi ^a   Kato, Nobumasa ^b   Kato, Tadafumi ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Bipolar disorder; Electroencephalogram; Lithium

Indexed keywords

LITHIUM;

ALPHA RHYTHM; ARTICLE; BETA RHYTHM; BIPOLAR DISORDER; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PATIENT INFORMATION; PREDICTION; SPIKE WAVE; THETA RHYTHM; TREATMENT OUTCOME;

BIPOLAR DISORDER; CHI-SQUARE DISTRIBUTION; DRUG RESISTANCE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; LITHIUM CHLORIDE; MALE; RETROSPECTIVE STUDIES;

EID: 0036592253     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00203-8     Document Type: Article

References (38)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth ed.: DSM-IV. 1994;American Psychiatric Association Press, Washington, DC.
2. Carroll B.J. Prediction of treatment outcome with lithium. Arch. Gen. Psychiatry. 36:1979;870-878.
3. Casper R.C., Pandey G., Gosenfeld L., Davis J.M. Intracellular lithium and clinical response. Lancet. 2:1976;418-419.
4. Cazzullo C.L., Smeraldi E., Scchetti E., Bottinelli S. Intracellular lithium concentration and clinical response. Br. J. Psychiatry. 126:1975;298-300.
5. Cook B.L., Shunkla S., Hoff A.L. EEG abnormalities in bipolar affective disorder. J. Affect. Disord. 11:1986;147-149.
6. Del Vecchio M., Farzati B., Maj M., Minucci P., Guida L., Kemali D. Cell membrane predictors of response to lithium prophylaxis of affective disorders. Neuropsychobiology. 7:1981;243-247.
7. Greil W., Kleindienst N., Erazo N., Muller-Oerlinghausen B. Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder. J. Clin. Psychopharmacol. 18:1998;455-460.
8. Harvey N.S., Kay R. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse. J. Clin. Psychopharmacol. 11:1991;362-367.
9. Hegerl U., Ulrich G., Muller-Oerlinghausen B. Auditory evoked potentials and response to lithium prophylaxis. Pharmacopsychiatry. 20:1987;213-216.
10. Hegerl U., Wulff H., Muller-Oerlinghausen B. Intensity dependence of auditory evoked potentials and clinical response to prophylactic lithium medication, a replication study. Psychiatry Res. 44:1992;181-190.
11. Heninger G.R. Lithium carbonate and brain function. Arch. Gen. Psychiatry. 35:1978;228-233.
12. Hitzemann R., Mark C., Hirschowitz J., Garver D. RBC lithium transport in the psychoses. Biol. Psychiatry. 25:1989;296-304.
13. Jasper H.H. Report of the committee on methods of clinical examination in electroencepharography. Electroencepharogr. Clin. Neurophysiol. 10:1958;370-375.
14. 31P-MRS in bipolar disorder. Int. J. Neuropsychopharmacol. 3:2000;83-85.
15. Kato T., Fujii K., Kamiya A., Kato N. White matter hyperintensity detected by magnetic resonance imaging and lithium response in bipolar disorder, a preliminary observation. Psychiatry Clin. Neurosci. 54:2000;117-120.
16. Knorring L., Oreland L., Perris C., Wiberg A. Evaluation of the lithium RBC/plasma ratio as a predictor of the prophylactic effect of lithium treatment in affective disorders. Pharmakopsychiatr. Neuropsychopharmakol. 9:1976;81-84.
17. Kocsis J.H., Kantor J.S., Lieberman K.W., Stokes P.E. Lithium ratio and maintenance treatment response. J. Affect. Disord. 4:1982;213-218.
18. Maj M., Del Vecchio M., Starace F., Pirozzi R., Kemali D. Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables. Acta Psychiatr. Scand. 69:1984;37-44.
19. Maj M., Arena F., Lovero N., Pirozzi R., Kemali D. Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder. Pharmacopsychiatry. 18:1985;309-313.
20. Maj M., Pirozzi R., Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J. Affect. Disord. 17:1989;237-241.
21. Mendels J., Frazer A. Intracellular lithium concentration and clinical response: towards a membrane theory of depression. J. Psychiatr. Res. 10:1973;9-18.
22. Mendels J., Frazer A., Baron J., Kukopulos A., Reginaldi D., Tondo L., Caliari B. Intra-erythrocyte lithium ion concentration and long-term maintenance treatment. Lancet. 1:1976;966.
23. Perris C. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses: VIII. Clinical-electroencephalographic investigation. Acta Psychiatr. Scand. 42(Suppl. 194):1966;118-152.
24. Prien R.F., Point P., Caffey E.M. Jr., Klett C.J. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch. Gen. Psychiatry. 28:1973;337-341.
25. Report of the APA Task Force (1975). The current status of lithium therapy. Am. J. Psychiatry 132, 997-1001.
26. Rybakowski J., Chlopocka M., Kapelski Z., Henacka B., Szajnerman Z., Kasprzak K. Red blood cell lithium index in patients with affective disorders in the course of lithium prophylaxis. Int. Pharmacopsychiatry. 9:1974;166-171.
27. Secunda S.K., Katz M.M., Swann A.C., Koslow S.H. Mixed mania: diagnosis and treatment. Swann A.C. Mania: New Research and Treatment. 1986;79-94 American Psychiatric Association Press, Washington, DC.
28. Small J.G., Milstein V., Medlock C.E. Cliical EEG findings in mania. Clin. Electroencephalogr. 28:1997;229-235.
29. Small J.G., Milstein V., Malloy F.W., Medlock C.E., Klapper M.H. Clinical and quantitative EEG studies of mania. J. Affect. Disord. 53:1999;217-224.
30. Steen V.M., Lovlie R., Osher Y., Belmaker R.H., Berle J.O., Gulbrandsen A.K. The polymorphic inositol polyphosphate 1-phosphatase gene as a candidate for pharmacogenetic prediction of lithium-responsive manic-depressive illness. Pharmacogenetics. 8:1998;259-268.
31. Swann A.C., Berman N., Frazer A., Koslow S.H., Secunda S. Lithium distribution in mania: plasma and red blood cell lithium, clinical state, and monoamine metabolites during lithium treatment. Psychiatry Res. 20:1987;1-12.
32. Takahashi R. Lithium treatment in affective disorders: therapeutic plasma level. Psychopharmacol. Bull. 15:1979;32-35.
33. Takahashi R., Sakuma A., Itoh K., Itoh H., Kurihara M., Saito M., Watanabe M. Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of the collaborative study group on treatment of mania in Japan. Arch. Gen. Psychiatry. 32:1975;1310-1318.
34. Tondo L., Baldessarini R.J., Floris G. Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders. Br. J. Psychiatry. 178(Suppl. 41):1901;184-190.
35. Ulrich G., Herrmann W.M., Hegerl U., Muller-Oerlinghausen B. Effect of lithium on the dynamics of electroencephalographic vigilance in healthy subjects. J. Affect. Disord. 20:1990;19-25.
36. Viguera A.C., Tondo L., Baldessarini R.J. Sex differences in response to lithium treatment. Am. J. Psychiatry. 157:2000;1509-1511.
37. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. 1992;World Health Organization, Geneva.
38. Zvolsky P., Dvorakova M., Vinarova E., Soucek K., Dostal T., Krulik R., Filip V. Proceedings: genetic aspects of lithium ratio in red blood cells and in plasma of manic-depressive patients. Act. Nerv. Super. 17:1975;271-272.